Literature DB >> 35446365

Error in Byline.

.   

Abstract

Entities:  

Year:  2022        PMID: 35446365      PMCID: PMC9024388          DOI: 10.1001/jamaophthalmol.2022.1066

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   8.253


× No keyword cloud information.
  1 in total

1.  Plasma Levels of Bevacizumab and Vascular Endothelial Growth Factor After Low-Dose Bevacizumab Treatment for Retinopathy of Prematurity in Infants.

Authors:  M Elizabeth Hartnett; David K Wallace; Trevano W Dean; Zhuokai Li; Charline S Boente; Eniolami O Dosunmu; Sharon F Freedman; Richard P Golden; Lingkun Kong; S Grace Prakalapakorn; Michael X Repka; Lois E Smith; Haibo Wang; Raymond T Kraker; Susan A Cotter; Jonathan M Holmes
Journal:  JAMA Ophthalmol       Date:  2022-04-01       Impact factor: 8.253

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.